![]() |
Tuesday, June 6, 2006
PATH gets Gates grant
$27.8 million to improve access to cancer vaccine
Now that the Western world has developed a vaccine to help prevent cervical cancer, Seattle-based PATH will lead a $27.8 million project that aims to make sure the new vaccine against human papillomavirus (HPV) also gets to poor women in the developing world.
"Cervical cancer disproportionately affects women in developing countries because infrastructure is lacking," said Dr. Jacqueline Sherris, director of the cervical cancer program at the Program for Appropriate Technology in Health.
PATH, a non-profit international health promotion organization, announced Monday that it had received the grant from the Bill & Melinda Gates Foundation to identify obstacles to delivering the vaccine in poor countries and to come up with potential solutions to problems of access.
Cervical cancer kills a quarter of a million women every year, most of them in poor countries. Two types of HPV are believed to cause 70 percent of all cervical cancer cases.
PATH, working with the World Health Organization as well as the drug firms Merck and GlaxoSmithKline, will conduct research in India, Peru, Uganda and Vietnam in an effort to reduce barriers to introducing the HPV vaccine in such countries.
![]() Day in Pictures Arduous climbs and more |
![]() David Horsey Polar bears left in the cold... |
![]() Tourism Visiting Seattle? Our guide on sights to see |

more
more
more
The Big Blog
Strange Bedfellows
Seattle Real Estate News
Seattle Traffic

101 Elliott Ave. W.
Seattle, WA 98119
(206) 448-8000
Home Delivery: (206) 464-2121 or (800) 542-0820
seattlepi.com serves about 1.7 million unique visitors
and 30 million page views each month.
Send comments to newmedia@seattlepi.com
Send investigative tips to iteam@seattlepi.com
©1996-2008 Seattle Post-Intelligencer
Terms of Use/Privacy Policy
